Has hepatic failure been reported in patients taking deferasirox?

Hepatic failure, including fatal cases, has been reported after marketing in patients taking deferasirox; most reports involved significant comorbidities, including pre-existing chronic liver conditions and multi-organ failure, and a contributing or aggravating role of deferasirox cannot be excluded.